Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Why AeroClean Technologies Is Trading Higher By Over 39%; Here Are 26 Stocks Moving Premarket

Published 04/10/2022, 11:18
Updated 04/10/2022, 12:10
© Reuters.  Why AeroClean Technologies Is Trading Higher By Over 39%; Here Are 26 Stocks Moving Premarket

Gainers

Bit Brother Limited (NASDAQ: BTB) rose 91.7% to $0.2150 in pre-market trading after declining around 14% on Monday.

AeroClean Technologies, Inc. (NASDAQ: AERC) shares rose 39.3% to $4.47 in pre-market trading. AeroClean Technologies and Molekule, Inc. agreed to combine the companies in an all-stock merger.

FingerMotion, Inc. (NASDAQ: FNGR) rose 28% to $8.32 in pre-market trading after jumping around 93% on Monday.

Adeia Inc (NASDAQ: ADEA) rose 27.4% to $9.16 in pre-market trading after Monday's spinoff of Xperi as an independent company.

IMAC Holdings, Inc. (NASDAQ: BACK) rose 20% to $0.48 in pre-market trading after gaining over 5% on Monday.

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) rose 18.8% to $8.45 in pre-market trading after jumping over 15% on Monday.

Immutep Limited (NASDAQ: IMMP) rose 15.4% to $1.84 in pre-market trading. Immutep recently received A$2.7 million R&D tax incentive from French government.

Smart for Life, Inc. (NASDAQ: SMFL) rose 15% to $0.4499 in pre-market trading.

Borqs Technologies, Inc. (NASDAQ: BRQS) rose 12.7% to $0.82 in pre-market trading. Borqs said its solar energy storage subsidiary recently signed an agreement to provide solar + energy storage systems to commercial and residential property in Hawaii.

Poshmark, Inc (NASDAQ: POSH) rose 11.7% to $17.39 in pre-market trading after the company agreed to be bought by Korea's largest internet company, Naver Corp, for $17.90 per share in cash.

American Rebel Holdings, Inc. (NASDAQ: AREB) rose 10.4% to $0.3975 in pre-market trading after gaining around 9% on Monday.

Global Medical REIT Inc. (NYSE: GMRE) rose 9.7% to $9.50 in pre-market trading.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Navitas Semiconductor Corporation (NASDAQ: NVTS) rose 9.6% to $5.58 in pre-market trading after gaining 5% on Monday.

DLocal Limited (NASDAQ: DLO) rose 9.2% to $23.29 in pre-market trading after gaining 4% on Monday.

NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) rose 8.4% to $13.73 in pre-market trading.

Rivian Automotive, Inc. (NASDAQ: RIVN) rose 7.8% to $34.39 in pre-market trading after the company issued an update on production and deliveries for the third quarter and said it remains on track to reach its previously provided production guidance. The company said it produced 7,363 vehicles and delivered 6,584 vehicles during the third quarter, its highest quarterly totals ever.

Under Armour, Inc. (NYSE: UAA) rose 6.5% to $7.49 in pre-market trading after gaining around 6% on Monday.

Don’t forget to check out our premarket coverage here .

Losers

Oblong, Inc (NASDAQ: OBLG) fell 24.6% to $0.3018 in pre-market trading after jumping 167% on Monday.

FaZe Holdings Inc. (NASDAQ: FAZE) fell 23.1% to $6.27 in pre-market trading after dropping over 15% on Monday.

FedNat Holding Company (NASDAQ: FNHC) shares fell 20.7% to $0.3718 in pre-market trading after surging around 309% on Monday.

Green Giant Inc. (NASDAQ: GGE) shares fell 17.7% to $0.89 in pre-market trading after declining over 5% on Monday.

eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) fell 11% to $0.5008 in pre-market trading. eFFECTOR Therapeutics recently named Mayank Gandhi, M.D., as Chief Business Officer.

Lottery.com Inc. (NASDAQ: LTRY) fell 9.2% to $0.2739 in pre-market trading after jumping 34% on Monday.

Theratechnologies Inc. (NASDAQ: THTX) shares fell 8.7% to $2.10 in pre-market trading. Theratechnologies announced FDA approval of Trogarzo for administration by IV push.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Atlis Motor Vehicles, Inc. (NASDAQ: AMV) fell 8.1% to $16.97 in pre-market trading after declining over 9% on Monday.

Acorda Therapeutics, Inc. (NASDAQ: ACOR) fell 6.8% to $0.3141 in pre-market trading after gaining over 12% on Monday.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.